Phase 2 biotech developing CAR-T cell therapies for hematological cancers.
Industry: Health Care
Latest Trade: $17.77 0.00 (0.0%)
First Day Return: -3.1%
Return from IPO: +18.5%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 10/20/2023 |
Offer Price | $15.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 18.8 |
Deal Size ($mm) | $281 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 11/09/2023 |
Offer Price | $15.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 18.8 |
Deal Size ($mm) | $281 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
J.P. Morgan |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | San Mateo, CA, United States |
Founded | 2019 |
Employees at IPO | 74 |
Website www.cargo-tx.com |